NCT00667862 2021-06-21Efficacy and Safety Study of Panobinostat in Participants With Metastatic Hormone Refractory Prostate CancerNovartisPhase 2 Completed35 enrolled 8 charts
NCT00939159 2018-08-23Study of LBH589 for Patients With Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)M.D. Anderson Cancer CenterPhase 2 Terminated17 enrolled 5 charts
NCT00632489 2015-06-08LBH589 in Combination With Capecitabine Plus/Minus (±) Lapatinib in Breast Cancer PatientsSCRI Development Innovations, LLCPhase 1 Completed20 enrolled 5 charts